SCHEMBL2372170

SCHEMBL2372170

O=S(=O)(NC1CC1)c1ccc(F)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.68
KDM4E B2RXH2 1/20 0.68
RECQL P46063 1/20 0.68
KMT2A Q03164 1/20 0.66
TDP1 Q9NUW8 1/20 0.66
ALDH1A1 P00352 4/20 0.56
CYP3A4 P08684 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
HTT P42858 1/20 0.56
MAP2K7 O14733 1/20 0.56
MAP2K4 P45985 1/20 0.56
PSEN1 P49768 1/20 0.55
PSEN2 P49810 1/20 0.55
APH1B Q8WW43 1/20 0.55
NCSTN Q92542 1/20 0.55
APH1A Q96BI3 1/20 0.55
PSENEN Q9NZ42 1/20 0.55
UCHL1 P09936 1/20 0.55
HTR1A P08908 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28111321 0.92 SMN1; SMN2 (0.75) SMN1; SMN2KDM4ERECQLKMT2ATDP1
SCHEMBL12332792 0.92 SMN1; SMN2 (0.81) SMN1; SMN2KDM4ERECQLKMT2ATDP1
SCHEMBL27248963 0.91 KDM4E (0.58) SMN1; SMN2KDM4ERECQLKMT2ATDP1
SCHEMBL27248964 0.91 KDM4E (0.58) SMN1; SMN2KDM4ERECQLKMT2ATDP1
SCHEMBL14842346 0.91 SMN1; SMN2 (0.79) SMN1; SMN2KDM4ERECQLKMT2AALDH1A1
SCHEMBL9594597 0.88 KDM4E (0.58) SMN1; SMN2KDM4ERECQLKMT2ATDP1
SCHEMBL4403614 0.88 KDM4E (0.58) SMN1; SMN2KDM4ERECQLKMT2ATDP1
Hydrochloric Acid SCHEMBL1392622 0.86 KDM4E (0.56) SMN1; SMN2KDM4ERECQLKMT2ATDP1
SCHEMBL23052020 0.82 UCHL1 (0.54) SMN1; SMN2KDM4ERECQLKMT2APSEN1
SCHEMBL23953194 0.82 APP (0.53) SMN1; SMN2KDM4ERECQLKMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2547204-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS Bayer Intellectual Property GmbH (DE) 2013-01-23 EP claimed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 US claimed
WO-2011113861-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 WO claimed
EP-2547204-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS Bayer Intellectual Property GmbH (DE) 2013-01-23 EP disclosed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 US disclosed
WO-2011113861-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS STS, ARSA, TST SMN1; SMN2 4603/4885KDM4E 2481/4885RECQL 1880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.